Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-054088
Filing Date
2017-02-23
Accepted
2017-02-23 16:38:09
Documents
71
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d347497d10k.htm 10-K 997390
2 EX-23.1 d347497dex231.htm EX-23.1 2385
3 EX-31.1 d347497dex311.htm EX-31.1 9815
4 EX-31.2 d347497dex312.htm EX-31.2 9629
5 EX-32.1 d347497dex321.htm EX-32.1 6050
12 GRAPHIC g347497g67f46.jpg GRAPHIC 60927
  Complete submission text file 0001193125-17-054088.txt   7271695

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20161231.xml EX-101.INS 1906094
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20161231.xsd EX-101.SCH 56802
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20161231_cal.xml EX-101.CAL 50407
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20161231_def.xml EX-101.DEF 417195
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20161231_lab.xml EX-101.LAB 374946
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20161231_pre.xml EX-101.PRE 443365
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 17633084
SIC: 2834 Pharmaceutical Preparations